Global Medical REIT (GMRE) Stock Price, News & Analysis

0 Wall Street research analysts have issued 12-month target prices for Global Medical REIT's shares. Their GMRE share price targets range from $11.00 to $12.50. On average, they predict the company's share price to reach $11.50 in the next year. This suggests a possible upside of 41.6% from the stock's current price.
View analysts price targets for GMRE or view top-rated stocks among Wall Street analysts.

Global Medical REIT's stock was trading at $11.10 at the beginning of 2024. Since then, GMRE shares have decreased by 26.8% and is now trading at $8.12.
View the best growth stocks for 2024 here.

Global Medical REIT saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 1,250,000 shares, an increase of 7.8% from the February 29th total of 1,160,000 shares. Based on an average trading volume of 376,200 shares, the days-to-cover ratio is currently 3.3 days.
View Global Medical REIT's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our GMRE earnings forecast.

Global Medical REIT Inc. (NYSE:GMRE) issued its quarterly earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a net margin of 12.55% and a trailing twelve-month return on equity of 3.20%. During the same period last year, the business posted $0.24 earnings per share.

Global Medical REIT announced a quarterly dividend on Thursday, March 7th. Shareholders of record on Friday, March 22nd will be given a dividend of $0.21 per share on Tuesday, April 9th. This represents a $0.84 annualized dividend and a dividend yield of 10.34%. The ex-dividend date of this dividend is Thursday, March 21st.
Read our dividend analysis for GMRE.

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 10.53%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 365.22%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 88.42% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

ETFs with the largest weight of Global Medical REIT (NYSE:GMRE) stock in their portfolio include Invesco KBW Premium Yield Equity REIT ETF (KBWY), ALPS REIT Dividend Dogs ETF (RDOG), Sound Enhanced Fixed Income ETF (FXED), Sound Enhanced Fixed Income ETF (SDEF) and Arrow Dow Jones Global Yield ETF (GYLD).iShares Residential and Multisector Real Estate ETF (REZ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

Global Medical REIT (GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sound Income Strategies LLC (1.64%), Allspring Global Investments Holdings LLC (0.35%), Pensionfund DSM Netherlands (0.25%), Royal Fund Management LLC (0.13%), Pensionfund Sabic (0.11%) and First Dallas Securities Inc. (0.06%). Insiders that own company stock include Henry Cole and Jeffrey Busch.
View institutional ownership trends.

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.